Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection

ClinicalTrials.gov ID: NCT00096785

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00096785. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Open-Label, Comparative Study to Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Naive Adults With Chronic Hepatitis B Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate antiviral activity and efficacy of entecavir (ETV) compared to adefovir in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine.

Study identification

NCT ID: NCT00096785
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Bristol-Myers Squibb; Industry
Enrollment: 69 participants

Conditions and interventions

Conditions

Interventions

entecavir Drug
adefovir Drug

Drug

Eligibility (public fields only)

Age range: 16 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 2004 (Type not available)
Primary completion: Jan 2006 (Actual)
Completion: Apr 2008 (Actual)
Last update posted: Aug 10, 2010

2004 – 2008

United States locations

U.S. sites: 11
U.S. states: 6
U.S. cities: 10

Facility	City	State	ZIP	Site status
Local Institution	San Diego	California	—	—
Local Institution	San Francisco	California	—	—
Local Institution	Torrance	California	—	—
Local Institution	Miami	Florida	—	—
Local Institution	North Miami Beach	Florida	—	—
Local Institution	Baltimore	Maryland	—	—
Local Insitution	New York	New York	—	—
Local Institution	New York	New York	—	—
Local Institution	Philadelphia	Pennsylvania	—	—
Local Institution	Dallas	Texas	—	—
Local Institution	Galveston	Texas	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00096785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 10, 2010 · Synced Nov 15, 2026